About Us
from seed to market.
The Trendlines Group invests in innovations in agrifood technologies and medtech, leveraging our experience, network, and resources to go from seed to market.
Stories
Vensica has developed minimally invasive solutions in urology, unlocking the unique properties of therapeutic ultrasound to deliver neurotoxins.
Working with Trendlines
Vensica’s journey from our establishment in 2014, through to our strategic partnership with Merz and the latest investment round, took many twists and turns. Trendlines was there for us at each stage.
Avner Geva, CEO Vensica Therapeutics
Achievements
Strategic license and collaboration agreement with Merz Therapeutics
Full development of a needle-less delivery system utilizing the power of therapeutic ultrasound
$19 million investment round led by Israeli VC IBF
Phytolon revolutionizes the way food colors are produced, bringing natural colors to the next level in terms of ...
Working with Trendlines
The investments of DSM Venturing, Cibus Fund, and Ginkgo Bioworks open the door for broad penetration of our products in the global food industry. We are excited to have new investors who share our vision to create healthy, efficient, and sustainable food systems via biotechnology.
Halim Jubran PhD, Co-founder and CEO of Phytolon
Achievements
Closed $14.5 million Series A funding round
Signed collaboration with Ginkgo Bioworks
Selected as one of top 30 global start-ups at SLINGSHOT 2019, Singapore, November 2019
Portfolio
How we do it
Our global team brings together science, technology, and business expertise to invest in and build innovation-based healthcare and agrifood companies.
News
5 September 2023
ViAqua Therapeutics announces $8.25M investment led by S2G Ventures to scale RNA-based solutions in aquaculture
Funding will enable ViAqua to bring its first product to market, invest...
11 September 2023
Limaca Medical Receives FDA 510(k) Clearance
Limaca Medical Receives FDA 510(k) Clearance for its Breakthrough Precision GI™ Endoscopic...
26 June 2023
Escala Medical awarded €5.5 million EIC funding to revolutionize pelvic organ prolapse treatment
Contact.
Misgav, Israel
Misgav Business Park, 17 T’chelet Street M.P. Misgav, 2017400
Tel: +972.72.260.7000
info@trendlines.com
Singapore
Blk 77, Ayer Rajah Crescent, #02-21/26 Singapore, 139954
Tel: +65.6461.7000
info@trendlines.com
